Brain implants fuel U.S.-China bioscience rivalry

Brain implants, such as those developed by Neuralink, are sparking a significant rivalry between the U.S. and China in the field of life sciences, driven by the potential to revolutionize treatments for neurological conditions like strokes and Parkinson's disease. Tech billionaires' massive investments in biotech startups are accelerating these advancements, but national security concerns are also mounting as the U.S. worries about China's rapid progress in this area. This competition underscores the broader implications for global health and tech innovation, highlighting the stakes involved in the next frontier of medical technology.